Skip to main content
SpringerLink
Log in

Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Objective

To evaluate the efficacy of F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG PET/CT) in differentiating malignant from benign pathologic fractures.

Materials and methods

F-18 FDG PET/CT was performed on 34 patients with pathologic fractures between May 2004 and June 2007. Fractures were located in tubular bones (26), in the pelvis (six), in the spine (one) and in a rib (one). The FDG uptake pattern at the fracture site was described, whether FDG uptake occurred in the marrow or cortex and soft tissue. Maximum standardized uptake values (SUVmax, the largest value at the region of interest) were measured at the fracture site, including cortical bone, bone marrow and soft tissue. As a reference standard, biopsy was used for 12 patients and clinical follow-up for 22 patients. Sensitivity, specificity and diagnostic accuracy of PET/CT were calculated.

Results

There were 19 malignant and 15 benign fractures. In the malignant fractures, PET/CT demonstrated high (mean SUVmax 12.0, range 4.3 to 45.7) F-18 FDG uptake in bone marrow in most cases (17 of 19). In benign fractures, there was low FDG uptake (mean SUVmax 2.9, range 0.6 to 5.5) within cortical bone or adjacent soft tissue around the fracture, rarely in the marrow. There were significant differences in the pattern of intramedullary FDG uptake (P < 0.001) and in the mean SUVmax (P < 0.01) between malignant and benign fractures. The sensitivity, specificity and diagnostic accuracy of F-18 FDG PET/CT were 89.5%, 86.7% and 88.2%, respectively, with a cut-off SUVmax set at 4.7. The time interval between fracture and PET/CT did not significantly influence FDG uptake at the fracture site.

Conclusion

F-18 FDG PET/CT reliably differentiated between malignant and benign fractures based on the SUVmax and based on medullary uptake, which was characteristic for malignant fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2(9): 683–693.

    Article  CAS  Google Scholar 

  2. Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, et al. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 2000; 231(3): 380–386.

    Article  CAS  Google Scholar 

  3. Wu H, Dimitrakopoulou-Strauss A, Heichel TO, et al. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUVmax in comparison to Patlak analysis. Eur J Nucl Med 2001; 28(6): 704–710.

    Article  CAS  Google Scholar 

  4. Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology 2007; 243(1): 204–211.

    Article  Google Scholar 

  5. Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 2007; 106(1): 29–34.

    Article  Google Scholar 

  6. Iagaru A, Quon A, McDougall IR, Gambhir SS. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Clin Nucl Med 2006; 31(12): 754–760.

    Article  Google Scholar 

  7. McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005; 184(4): 1293–1304.

    Article  Google Scholar 

  8. Paul R, Ahonen A, Virtama P, Aho A, Ekfors T. F-18 fluorodeoxyglucose: its potential in differentiating between stress fracture and neoplasia. Clin Nucl Med 1989; 14(12): 906–908.

    Article  CAS  Google Scholar 

  9. Schmitz A, Risse JH, Textor J, et al. FDG-PET Findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos Int 2002; 13(9): 755–761.

    Article  Google Scholar 

  10. Shon IH, Fogelman I. F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 2003; 28(3): 171–175.

    PubMed  Google Scholar 

  11. Kato K, Aoki J, Endo K. Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase. Ann Nucl Med 2003; 17(1): 41–46.

    Article  Google Scholar 

  12. Katzel JA, Heiba SI. PET/CT F-18 FDG scan accurately identifies osteoporotic fractures in a patient with known metastatic colorectal cancer. Clin Nucl Med 2005; 30(10): 651–654.

    Article  Google Scholar 

  13. Tsuchida T, Kosaka N, Sugimoto K, Itoh H. Sacral insufficiency fracture detected by FDG-PET/CT: report of 2 cases. Ann Nucl Med 2006; 20(6): 445–448.

    Article  Google Scholar 

  14. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219(3): 774–777.

    Article  CAS  Google Scholar 

  15. Meyer M, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med 1994; 19(1): 13–14.

    Article  CAS  Google Scholar 

  16. Ravenel JG, Gordon LL, Pope TL, Reed CE. FDG-PET uptake in occult acute pelvic fracture. Skeletal Radiol 2004; 33(2): 99–101.

    Article  Google Scholar 

  17. Zhuang H, Sam JW, Chacko TK, et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging 2003; 30(8): 1096–1103.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery College of Medicine, Yeungnam University, Daegu, Korea

    D.-S. Shin, O.-J. Shon & S.-J. Byun

  2. Department of Surgical Pathology, College of Medicine, Yeungnam University, Daegu, Korea

    J.-H. Choi

  3. Department of Nuclear Medicine, College of Medicine, Yeungnam University, 317-1 Daemyung-Dong, Nam-Gu, Daegu, 705-717, Republic of Korea

    K.-A. Chun & I.-H. Cho

Authors
  1. D.-S. Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O.-J. Shon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S.-J. Byun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J.-H. Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K.-A. Chun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I.-H. Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D.-S. Shin.

Additional information

This research was supported by the Yeungnam University research grants in 2007.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, DS., Shon, OJ., Byun, SJ. et al. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Skeletal Radiol 37, 415–421 (2008). https://doi.org/10.1007/s00256-008-0462-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-008-0462-3

Keywords

Search

Navigation